Valuable lessons from treatment of non-small cell lung cancer with erlotinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor
2008 ◽
Vol 2008
(nov12 1)
◽
pp. bcr0620080075-bcr0620080075
◽
2016 ◽
Vol 24
(5)
◽
pp. 263-279
◽
2017 ◽
Vol 32
(3)
◽
pp. 422-428
◽
2018 ◽
Vol 7
(S4)
◽
pp. S377-S380
◽
2014 ◽
Vol 34
(3)
◽
pp. 865-872
◽
2013 ◽
Vol 19
(4)
◽
pp. 594-600
◽